ACE2 and uveitis: In experimental models of mouse autoimmune uveitis or endotoxin-induced uveitis, the delivery of different formulations of ACE2 and/or its product Ang(1-7) or the administration of an ACE2 activator reduced retinal inflammation (Qiu et al., 2014, 2016; Shil et al., 2014) and prevented histologic damage as well as ERG abnormalities (Qiu et al., 2016).